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Identification and 
Characterization of Sclerotium 
rolfsii Lectin (SRL) Binding 
Proteins from Human Colon 
Epithelial Cancer HT29 Cells
Abstract
Background: TF antigen specific Sclerotium rolfsii lectin (SRL) inhibits human 
colon epithelial cancer HT29 cell growth by induction of apoptosis through cell 
surface binding and has tumor suppressing effect in vivo as reported earlier. Here 
we report the purification, identification and characterization of SRL binding 
membrane proteins from HT29 cells.
Methods and Findings: Membrane proteins from HT29 cells were isolated by 
phase separation and purified by affinity chromatography using SRL-Sepharose-
4B matrix. Affinity purified proteins were subjected to in-gel and in-solution 
trypsin digestion, analysed by ESI-Q-TOF LC-MS and spectrum mill software. 
Considering the specificity of SRL towards O-glycans, the presence of O-GalNAc 
sites in SRL interacting proteins were tested using NetOGlyc software. Western 
blotting was performed to validate the MS identified proteins. A major protein 
band around 25kDa following in-gel trypsin digestion was identified as Keratin 1 
by MS. In-solution trypsin digestion followed by MS identified 25 SRL interacting 
proteins namely, keratins, heat shock proteins, tubulins, pyruvate kinase M1/M2, 
peroxiredoxin-1, ATP synthase subunit alpha, mitochondrial, retinal dehydrogenase 
1, actin, annexin-A2, prohibitin, ADP/ATP translocase-2 and alpha enolase. 
NetOGlyc software analysis revealed 21 proteins positive for O-glycosylation sites 
including keratins alone containing 27 to 50 O-GalNAc sites. Keratin 1 identified 
and validated by western blotting as major SRL interacting protein showed 49 
O-GalNAc sites. 
Conclusion: SRL binding membrane proteins from human colon epithelial cancer 
HT29 cells have been identified and characterized. Identified proteins contain 
O-GalNAc sites and are known to be involved in cell survival, apoptosis and 
tumorigenesis. The present study provides insights in studying the mechanism of 
SRL induced apoptosis and to explore lectin for its clinical implications.
Key words: Sclerotium rolfsii lectin; HT29 cell membrane proteins; NetOGlyc 
version 4.0; Q-TOF-LC/MS; Spectrum Mill. 
Abbreviations: SRL: Sclerotium rolfsii lectin; LC/MS: Liquid chromatography/Mass 
spectrometry; ESI: Electro Spray Ionization; Q-TOF: Quadrupole- Time of Flight; 
PTM: Post Translational Modification; ACN: Acetonitrile; CBB: Coomassie Brilliant 
Blue; BSA: Bovine Serum Albumin.
Introduction 
Lectins are carbohydrate-binding proteins of non-immune 
origin possessing at least one non-catalytic domain that binds 
reversibly to specific mono- or oligosaccharides [1]. Lectins are 
known for their affinities to carbohydrates and hence have been 
used to detect sugar moieties on normal and transformed cell 
surfaces and to study the structural and functional role of cell 
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surface glycans/receptors [2,3]. Lectins are also valuable tools in 
understanding various physiological processes like cell adhesion 
and localization, signal transduction across membranes, mitogenic 
stimulation, augmentation of host immune defence, cytotoxicity 
and apoptosis [4]. Some plant and fungal lectins are shown to 
elicit diverse physiological responses such as mitogenic, anti-
proliferative, anti-tumour, antifungal and immunomodulatory 
activities that are generally initiated by recognizing and binding to 
membrane proteins [5,6]. Some lectins such as Peanut agglutinin 
(PNA), Amaranthus caudatus agglutinin (ACA), Agaricus bisporous 
lectin (ABL), Jacalin (JAC), Agrocybe aegerita lectin (AAL) and SRL 
are known to recognize cancer associated Thomsen-Friedenreich 
antigen (Galβ1–3GalNAc-α-O-Ser/Thr, T or TF) and their 
derivatives and are known for exerting their growth stimulatory 
or inhibitory or apoptosis inducing effect on these cancer cells 
[7]. Hence identification of specific target cell membrane proteins 
of TF binding lectins unravels the initial event in the primary 
action of these lectins on cancer cells and consequent activation 
of the signalling pathways upon lectin binding [8,9]. Lectin affinity 
chromatography in combination with mass spectrometry is a 
powerful tool to identify the membrane proteins recognised by 
lectins [10]. Identification of lectin interacting proteins is of great 
significance as it further strengthens clinical application of these 
lectins in cancer therapeutics.
Our earlier studies have shown that antitumor lectin from 
Sclerotium rolfsii (SRL) is involved in development and 
morphogenesis of fungus [11,12]. Crystal structure of SRL has 
been determined in its free form at 1.1 A˚ resolution [13]. Glycan 
array analysis has revealed the exquisite binding specificity of 
Sclerotium rolfsii lectin towards TF antigen and its derivatives [14]. 
Recent studies have shown that SRL inhibits cancer cell growth 
and induces apoptosis in human colon epithelial cancer HT29, 
ovarian cancer PA1 and breast cancer MCF7 cells by involving 
both intrinsic and extrinsic pathways as a consequence of its 
cell surface binding [15-17]. Antitumor effect of SRL has been 
demonstrated in NOD-SCID mice bearing HT29 xenografts in vivo 
[15]. Gene expression profiling studies in HT29 cells following 
SRL interaction has revealed that lectin induced differential 
expression of genes involved in multiple signalling pathways like 
mitogen activated protein kinase (MAPK), insulin, cell cycle, DNA 
replication and apoptosis pathways [18]. 
In the current study, we report the identification of SRL interacting 
membrane proteins from human colon epithelial cancer HT29 
cells. The strategy of protein identification involved isolating 
SRL binding proteins from membrane enriched fraction by lectin 
affinity chromatography, followed by proteomics workflow 
approach using LCMS. The presence of O-GalNAc sites in SRL 
interacting proteins were predicted by NetOGlyc software and 
keratins identified as SRL binding proteins were validated by 
western blotting. 
Methods
Cell culture
HT29, human epithelial colorectal adenocarcinoma cells were 
obtained from the European Cell Culture Collection via the 
Public Health Laboratory Service (Porton Down, Wiltshire, UK). 
HT29 cells were cultured and maintained in DMEM (Dulbecco’s 
Modified Eagle’s Medium) supplemented with 10% FBS 
(Fetal Bovine Serum), 100 units/ml penicillin and 100 μg/ml 
streptomycin (Complete DMEM) at 37°C in 5% CO2.
Purification of SRL
SRL was purified from sclerotial bodies as mentioned earlier 
[11]. Briefly, SRL was extracted from sclerotial bodies of the 
fungus with 50 mM acetate buffer (pH 4.3) containing 100 mM 
NaCl and subjected to 30% methanol precipitation and then 
passed through ion exchange chromatography on CM cellulose 
column equilibrated with 50 mM acetate buffer(pH 4.3) 
containing 100 mM NaCl. The bound proteins were eluted with 
salt gradient from 100 to 600 mM of NaCl in the equilibration 
buffer. The protein peak fractions with hemagglutinating 
activity were pooled and dialyzed against 25 mM ethylene 
diamine-acetate buffer (pH 4.5) and finally the lectin was 
purified on Superdex G-75 gel filtration column equilibrated 
with 25 mM Tris-HCl buffer saline, pH 7.5.
Activation of Sepharose-4B and coupling of SRL
SRL coupled Sepharose-4B required for affinity pull down of lectin 
binding proteins was prepared by CNBr activation of Sepharose-
4B and coupling with SRL according to the method described 
by March et al. [19]. Briefly, Sepharose-4B was suspended in 2 
M sodium carbonate (1:1) for the activation and CNBr (0.05 
volume) in acetonitrile was added to the Sepharose-4B with 
constant stirring at room temperature (RT). The slurry was 
extensively washed with the 0.1 M carbonate buffer (pH 9.5) and 
resuspended in the binding buffer (0.2 M carbonate buffer, pH 
9.5). SRL (10 mg/ml) in binding buffer was added to the slurry and 
kept for coupling at 4°C for 20 h with constant shaking. Unreacted 
groups were masked by incubating the slurry with 1 M glycine for 
4 h. After coupling the slurry was extensively washed with 0.1 M 
acetate buffer (pH 4.5), 2 M urea and 0.1 M carbonate buffer (pH 
10) containing 0.5 M sodium chloride. SRL coupled Sepharose-
4B was suspended in 25 mM TBS pH 7.5 and stored at 4° C until 
further use. 
Membrane protein isolation
HT29 cells were grown in T75 flask in complete DMEM media 
until they reach the 85-90% confluence. 50× 106 cells were 
harvested by gentle trypsinization, washed with PBS and used for 
membrane protein isolation by “Mem per isolation kit” (Pierce, 
USA) as per the manufacturer’s instruction. Briefly, for 50×106 cell 
pellet, 1500 µl of Reagent A and 50 µl of PIC (Protease inhibitor 
complex, Calbiochem, USA) was added, mixed properly and 
incubated for 10 min at RT with occasional stirring. Lysed cells 
were placed on ice and 4500 µl of B+C (B:C=1:2) solution was 
added, vortexed and incubated on ice both for 30 min (vortexed 
at every 5 min). Samples centrifuged at 9000 rpm for 3 min at 4°C 
and resulting supernatant was incubated at 37°C for 20 min on 
water bath for phase separation. Samples centrifuged at 10000 
rpm for 2 min at RT to isolate hydrophobic fraction containing 
membrane proteins. Top layer containing hydrophilic phase was 
removed and the hydrophobic phase containing membrane 
protein was stored at -80°C prior to lectin affinity.
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SRL-affinity chromatography
SRL-Sepharose 4B and lectin affinity matrix was equilibrated 
with equilibration buffer TBS (25 mM Tris, pH 7.5, 0.15 M NaCl). 
The total membrane protein (2 mg) isolated from the HT29 cells 
was first applied to Sepharose-4B matrix (5 ml) and incubated 
overnight at 4°C on rocking, to exclude the proteins binding 
nonspecifically to the resin. Unbound proteins from matrix were 
collected by spinning and washing with the TBS. The protein 
fraction was then applied to lectin affinity matrix (5 ml) in a 
micro centrifuge tube pre-incubated with 3% BSA (Sigma Aldrich, 
USA) to block non-specific binding sites of affinity matrix and 
incubated for 12-14 h at 4°C on a rocking platform. Lectin-matrix 
column was extensively washed with the TBS to remove unbound 
proteins. After washing, SRL captured proteins were released by 
treating with elution buffer (25 mM Tris, pH 7.5, containing 0.15 
M NaCl and 5% SDS) for 12-14 h at 4°C and eluted fraction was 
collected by centrifuging the tubes at 3000 rpm for 5 min at 4°C 
and stored at -80°C. Protein concentration was determined by 
using protein estimation kit (Bio-Rad, Hercules, CA).
SDS-PAGE and trypsin digestion of membrane 
proteins 
Lectin affinity purified membrane proteins from the HT29 cells 
were separated by SDS-PAGE on 10% (w/v) acrylamide gels of 0.75 
mm thickness. Protein bands were visualized using Coomassie 
brilliant blue G-250 (Sigma Chemical Co., USA) and the sizes of 
the resolved proteins were compared with standard molecular 
weight markers (Merck, India). 
Preparation of samples for mass spectrometry analysis: For mass 
spectrometry analysis, affinity purified membrane proteins were 
subjected to Agilent’s in-gel and in-solution trypsin digestion 
protocol. Briefly, for in-gel digestion, each band was excised from 
the gel and destained using acetonitrile (ACN) and ammonium 
bicarbonate (Sigma Aldrich, USA) solution mixture (80 mg of 
Ammonium bicarbonate in 40 ml of 50% acetonitrile). Gel pieces 
were reduced with 50 mM dithiothreitol (DTT) (Sigma Aldrich, 
USA) for 20 min at 60°C and alkylated with 20 mM iodoacetamide 
(IAA) (Sigma Aldrich, USA) for 60 min at RT in dark. Gel pieces 
were dehydrated by soaking in 100% ACN for 5 min, dried using 
Speed Vac (Eppendorf) concentrator and rehydrated by adding 
trypsin solution (mass spectrometry grade, 1 µg of trypsin/20 µg 
of protein) (Promega, Madison, USA) and incubated overnight 
at 37°C. Supernatant was removed and the gels were extracted 
for peptides in 1% formic acid (Sigma Aldrich, USA). Both 
supernatants containing peptides were mixed and concentrated. 
Peptides were redissolved in water containing 3% acetonitrile 
and 0.1% Formic acid and analyzed on LCMS system.
For in-solution digestion, 50 µg of SRL purified membrane 
proteins were dissolved in 25 µl 2,2,2-trifluoroethanol (TFE) 
(Sigma Aldrich, USA) and 25 µl of ammonium bicarbonate 
(100 mM) and reduced with 2 ul of DTT (200 mM) for 60 min 
at 37°C and alkylated with 2 µl of IAA (200 mM) for 60 min at 
RT in dark. Sample was diluted by ammonium bicarbonate and 
digested using mass spectrometry grade trypsin solution (1:20) 
for overnight at 37°C. Trypsinization was inhibited by adding 1 
µl of formic acid. Sample was concentrated, redissolved in water 
containing 3% acetonitrile and 0.1% Formic acid and analyzed on 
LC/MS system.
HPLC, mass spectrometry and MS/MS identifica-
tion
The peptides from in-gel or in-solution digestion (5 µl) was applied 
to Agilent Polaris-HR-Chip-3C18 with a 360 nL enrichment column 
and 150 mm × 0.075 mm analytical column coupled with the 
Agilent 6550 iFunnel Q-TOF LC/MS System. The solvent system 
consisting of 0.1% formic acid in water (A); 90% acetonitrile in 
water with 0.1% formic acid (B) was used for the analysis. Spectra 
were recorded in positive ion mode. Data were acquired at 2 GHz 
(extended dynamic) and Agilent Spectrum Mill MS Proteomics 
Workbench was used for database search to identify SRL binding 
membrane proteins. 
Prediction of O-GalNAc sites in MS identified 
membrane proteins
O-GalNAc sites in MS identified SRL binding membrane proteins 
were predicted by using NetOGlyc version 4.0 software [20]. 
NetOGlyc version 4.0 is online software used to predict O-GalNAc 
glycosylation sites in the given protein sequence. SRL binding 
protein sequences were fetched from Uniprot database. FASTA 
sequence of these proteins were uploaded in NetOGlyc version 4.0 
software and processed to predict the potential O-glycosylation 
sites [20].
Western blotting 
SRL-affinity purified and total membrane proteins were 
electrophoresed on 10% SDS–polyacrylamide gels, and then 
blotted on to PVDF (Polyvinylidene difluoride) membrane 
(Millipore, USA) by wet method. Blots were blocked with 5% 
BSA, and then probed with Keratin 1 (Abcam, MA, USA), Keratin 8 
and Keratin 18 (Sigma Aldrich, USA) mouse primary monoclonal 
antibodies (1:500) for overnight at 4°C. Blots were washed thrice 
with TBST and incubated with species specific HRP conjugated 
secondary antibody (Bio-Rad Laboratories, USA) (1:1000) for 2 h. 
Blots were washed thrice with TBST and bands were visualized 
by using chemiluminescence with Immun-StarTM HRP Luminol/
Enhancer (Bio-Rad Laboratories, USA). The membranes were 
exposed to X-ray films, fixed and developed. 
Results
Isolation of membrane proteins and purification by 
using lectin affinity matrix 
2 mg of membrane proteins was isolated from 50×106 HT29 cells 
by phase separation using “Mem per isolation kit” and treated 
with immobilized lectin matrix. Affinity chromatography of SRL-
binding membrane proteins yielded 340 µg of proteins upon 
elution. 
Protein digestion
SRL purified HT29 membrane proteins for the mass spectrometry 
identification were prepared by both in-gel and in-solution tryptic 
digestion. In first method, SRL purified proteins were fractionated 
on the 10% SDS-PAGE (Figure 1A) and visual bands were processed 
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for in-gel tryptic digestion and in second method, affinity eluted 
sample in-solution form was directly used for trypsin digestion.
In-gel tryptic digestion and Q-TOFLC/MS identifica-
tion
SRL-affinity purified membrane proteins were resolved on the 
SDS-PAGE and stained with CBB. SDS-PAGE revealed 6 protein 
bands corresponding to approximate molecular weights of 
80kDa, 66kDa, two bands near 50kDa, 25kDa and 17kDa (Figure 
1A). The protein band near 25kDa was intense compared to other 
three protein bands pulled down by lectin affinity.
These protein bands were subjected for in-gel tryptic digestion 
and the tryptic digest was analysed by ESI-Q-TOF-LCMS/MS. 
Figure 1B shows representative MS/MS spectra of keratin 
peptides. Figure 2 displays in-gel digestion of band e protein 
at 25kDa and identification by Agilent’s Spectrum Mill analysis. 
Spectrum Mill search indicated that 14 and 11 peptides were 
matched with distinct summed MS/MS search score of 204.46 and 
158.31 for Keratin-1 and Keratin-1 isoforms (Keratin 1-7 isoforms) 
respectively. Protein bands b and f were identified as BSA and SRL 
respectively (Data not shown), BSA (Bovine Serum Albumin) was 
used for blocking of non-specific sites and probably the coupled 
SRL was leached out during affinity pull down chromatography. 
The protein identification from other three minor bands (a, c and 
d) did not result in any definite identification probably due to 
their low abundance.
In-solution tryptic digestion and Q-TOF-LC/MS 
identification
In second method, SRL-affinity purified membrane proteins 
were directly subjected for in-solution tryptic digestion and the 
digest was analysed by ESI-Q-TOF-LC/MS. Figure 3 displays in-
solution tryptic digest identified proteins by Agilent’s spectrum 
Mill software and Figure 4 displays MS/MS spectra of Keratin 1, 
annexin-A2, Tubulin alpha-1B chain, HSP 90 and actin. Spectrum 
Mill search from in-solution tryptic digestion method indicated 
that 22 peptides matched with distinct summed MS/MS search 
score 389.63 for Keratin-1. In a similar way 24 proteins excluding 
Keratin1 derived from in-solution, were also analyzed using 
the same methods used for identification of Keratin 1. The 
peptide matches and distinct summed MS/MS search scores 
etc. for other proteins are presented in Figure 3. A total of 25 
SRL interacting proteins were identified namely, keratins, heat 
shock proteins, ATP synthase subunit alpha, mitochondrial, 
retinal dehydrogenase 1, actin cytoplasmin-2, tubulins, pyruvate 
kinase-M1/M2, annexin-A2, peroxiredoxin-1, prohibitin, alpha 
enolase and ADP/ATP translocase-2. Table 1 presents SRL binding 
proteins, their molecular size, biological response and post 
translational modifications (PTM) as per the literature.
Prediction of O-GalNAc sites 
SRL binding proteins were checked for the presence of O-GalNAc 
sites by employing NetOGlyc version 4.0. Analysis by NetOGlyc 
version 4.0 revealed the presence of potential O-GalNAc sites in 
the identified proteins. Out of 25 proteins, 21 were found to be 
positive and four were negative for O-GalNAc sites. Supporting 
information 1 presents prediction of O-GalNAc sites of Keratin-1 
by NetOGlyc version 4.0. O-GalNac sites of other identified 
proteins were analysed in a similar way (data not shown). The 
number of potential O-GalNAc sites in the SRL interacting proteins 
is presented in Table 2.
Validation of keratins as SRL binding membrane 
proteins by western blotting 
Western blotting studies were carried out to check and validate 
keratins identified by MS as SRL binding membrane proteins as 
keratins are considered as a common contaminant in MS analysis. 
Membrane blots of total membrane proteins and lectin-affinity 
purified proteins probed with Keratin1, Keratin 8 and Keratin 18 
antibodies and the results are presented in Figure 4. A prominent 
Keratin 1 band was observed in SRL eluted and total membrane 
protein fraction confirming that Keratin 1 is the one of the 
binding partner of SRL. In contrast Keratin 8 and Keratin 18 were 
not detected in both the total membrane and SRL eluted fraction. 
Discussion
Antitumor effect of Sclerotium rolfsii lectin has been demonstrated 
earlier both by in vitro and in vivo studies in human colon 
epithelial cancer HT29 cells and NOD-SCID mice respectively [15], 
that demands the need to identify lectin interacting membrane 
proteins from these cells. In the present study, we report the 
identification of Sclerotium rolfsii lectin interacting membrane 
proteins containing O-GalNAc sites from human epithelial colon 
cancer HT29 cells. SRL-affinity chromatography was used to 
capture membrane proteins from HT29 cells and lectin interacting 
proteins were identified by mass spectrometry. The presence of 
O-GalNAc sites in the identified proteins was predicted using 
NetOGlyc version 4.0. MS investigation revealed 25 SRL binding 
proteins namely, keratins, heat shock proteins, ATP synthase 
subunit alpha, mitochondrial, retinal dehydrogenase 1, actin 
cytoplasmin-2, tubulins, pyruvate kinase-M1/M2, annexin-A2, 
peroxiredoxin-1, prohibitin, alpha enolase and ADP/ATP 
translocase-2 and some of these are membrane scaffold proteins. 
The present study is an attempt to identify SRL binding membrane 
proteins from enriched membrane fraction however we cannot 
rule out the possibility of copurification of associated membrane 
scaffold proteins and few cytosolic proteins. Interestingly these 
identified lectin interacting proteins are known to be involved 
in physiological process like cell cycle, apoptosis, angiogenesis, 
stress response, host-virus interaction, DNA synthesis and 
glycolysis and hence interaction of SRL with these proteins is 
likely to affect the said cellular processes. 
Keratin 1 is identified as one of the SRL binding membrane protein 
by MS both by in-gel and in-solution tryptic digestion. Since 
keratins are known to be common contaminants in MS analysis, 
we repeated the experiment thrice independently under stringent 
conditions to rule out that Keratin 1 identified as SRL binding 
protein is not a contaminant but a true SRL interacting protein. 
Further, the data was validated by western blotting analysis. 
Interestingly, in contrast to Keratin 1, Keratin 8 and Keratin 18 
identified as SRL binding proteins by MS were not detected in 
western blotting in both total and affinity purified fraction. This 
could be due to the fact that all the keratins identified by MS are 
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Figure 1 SDS-PAGE and MS MS spectra of peptides from in-gel trypsin digestion. (A) Affinity purified membrane proteins fractionated 
on 10% SDS PAGE, Mr represents standard molecular weight markers, lane 1 represents total membrane proteins and lane 2 
represents SRL eluted proteins, a, b, c, d, e and f. (B) Representative MS/MS spectra of Keratin 1 peptides from Spectrum Mill.
Figure 2  Lectin binding proteins identified from in-gel trypsin digestion. Identification of affinity purified membrane proteins from in-gel 
tryptic digest of band e of SDS-PAGE by MS/MS and Spectrum Mill.
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isoforms which share similar conserved sequences. MS identifies 
a protein by matching peptide sequences and hence peptides 
derived from tryptic digestion of Keratin 1 are likely hit others 
keratins. It is interesting to note that Keratin 1 identified as SRL 
Figure 3 Lectin binding proteins identified from in-solution trypsin digestion. Affinity purified membrane proteins subjected to in-solution 
tryptic digestion and identified by MS/MS and Spectrum Mill.
 
Figure 4 MS MS spectra of peptides from in-solution trypsin digestion and western blotting. Representative MS/MS spectra of (A) Kerain 
1, (B) Annexin-A2, (C) Tubulin alpha-1B chain, (D) HSP 90 and (E) Actin peptides. (F) Western blotting; Total membrane protein 
and SRL-affinity purified proteins from human colon cancer HT29 cells were transblotted to PVDF membrane and probed with 
Keratin 1 (K1), Keratin 8 (K8) and Keratin 18 (K18) monoclonal antibodies. Data are representatives of two similar experiments.
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Serial No. Identified proteins
Molecular weighta
   (kDa)
Biological responseb PTMc
1 Keratin 1, type II cytoskeletal 1 65
Complement activation, 
lectin pathway, Regulation 
of angiogenesis, Response 
to Oxidative stress, 
Fibrinolysis
Citrullination 
Methylation 
Phosphoprotein
2 Keratin, type II cytoskeletal 5 58 Cell junction assembly, Epidermis development -
3 Keratin, type I cytoskeletal 8 60 Host-virus interaction
Acetylation 
Glycoprotein 
Phosphoprotein
4 Keratin, type I cytoskeletal 9 62.06
Epidermis and 
skin development, 
Spermatogenesis
Phosphoprotein
5 Keratin, type I cytoskeletal 10 58.82
Cellular response to 
calcium ion, Keratinocyte 
differentiation
Phosphoprotein
6 Keratin, type II cytoskeletal 2 epidermal 65.43
Associated with keratinocyte 
activation, proliferation and 
keratinization
Phosphoprotein
7 Keratin, type II cytoskeletal 6B 60.06 Ectoderm development
Acetylation 
Phosphoprotein
8 Keratin, type I cytoseletal 14 51.56
Aging, Cell junction 
assembly, Epithelial cell 
differentiation, Response to 
ionizing radiation and zinc 
ion
Disulfide bond
9 Keratin, type I cytoskeletal 18 67
Cell cycle 
Host-virus interaction
Acetylation 
Glycoprotein 
Phosphoprotein
10 ADP-ribosylation factor 1 20.69
GTPase activity
Receptor signalling protein 
activity
Acetylation
Lipoprotein
11 Heat shock protein HSP 90-
beta
84 Stress response
Acetylation 
Glycoprotein 
Phosphoprotein 
S-nitrosylation 
Ubl conjugation
12 Annexin-A2 36
Angiogenesis, Membrane 
budding, Protein 
heterotetramerization
Acetylation 
Phosphoprotein 
Ubl conjugation
13 Alpha-enolase 47 Glycolysis
Acetylation 
Phosphoprotein 
Ubl conjugation
14 60 kDa heat shock protein, mitochondrial 60 Host-virus interaction
Acetylation 
Phosphoprotein
15 Tubulin beta-4B chain 49.83
'de novo' post-translational 
protein folding, G2/M 
transition of mitotic cell 
cycle
Acetylation 
Phosphoprotein
16 Tubulin alpha-1B chain 50.12 'de novo' posttranslational protein folding, Cell division
Acetylation 
Isopeptide bond 
Methylation 
Nitration 
Phosphoprotein 
Ubl conjugation
17 Peroxiredoxin-1 22 Cell proliferation, hydrogen 
peroxide catabolic process, 
Acetylation 
Disulfide bond 
Phosphoprotein
Table 1 Proteins identified by MS/MS as SRL interacting proteins, their biological role and PTM.
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18 Protein S100-A6 10 Signal transduction Acetylation
19 Elongation factor 1-alpha 2 50.47 Protein biosynthesis
Acetylation 
Methylation 
Phosphoprotein
20 Actin, cytoplasmic 2 42
Adherens and Cell-cell 
junction organization, 
Cellular component 
movement
Acetylation, Methylation, 
Oxidation
21 ADP/ATP translocase 2 32.85
Chromosome partition 
Host-virus interaction 
Transport
Acetylation 
Methylation
22 Prohibitin 29.80 DNA synthesis Acetylation Phosphoprotein
23 Pyruvate kinase isozymes 
M1/M2
57.93 Glycolysis
Acetylation 
Hydroxylation 
Phosphoprotein 
Ubl conjugation
24 ATP synthase subunit alpha, mitochondrial 59.75
ATP synthesis
Transport
Acetylation 
Glycoprotein 
Phosphoprotein
25 Retinal dehydrogenase 1 54.86 Cofactor and Retinol 
metabolism
Acetylation 
Phosphoprotein
aMolecular size, bbiological roles and cPTM are fetched from Uniprot database.
Serial No. SRL binding proteins
O-GalNAc sites with
*prediction score =>0.5
1 Keratin 1 49
2 Keratin 2 48
3 Keratin 5 50
4 Keratin 6B 34
5 Keratin 8 37
6 Keratin 9 48
7 Keratin 10 34
8 Keratin 14 27
9 Keratin 18 34
10 ATP synthase subunit alpha, mitochondrial 10
11 Retinal dehydrogenase 1 6
12 60 kDa heat shock protein, mitochondrial 5
13 Annexin-A2 4
14 Pyruvate kinase 
isozymes M1/M2
3
15 Prohibitin 2
16 Heat shock protein HSP 
90-beta
2
17 Peroxiredoxin-1 2
18 Actin cytploasmic 2 2
19 ADP/ATP translocase 2 1
20 Tubulin beta-4Bchain 1
21 Elongation factor 1-alpha 2 1
22 ADP-ribosylation factor 1 Nil
23 Protein S100-A6 Nil
24 Alpha-enolase Nil
25 Tubulin alpha-1B chain Nil
*Prediction confidence score => 0.5 are forecasted as glycosylated.
Table 2 O-GalNAc sites in SRL binding proteins as predicted by NetOGlyc 
version 4.0.
binding protein from in-gel digestion of band at approx. 25kDa 
but the actual molecular weight of Keratin 1 is approx. 65 kDa 
suggesting that this could be possibly modified keratin expressed 
either on the cell surface or as an integral membrane protein. 
There are reports on the expression of modified form of keratins 
with varying molecular mass that are expressed on cancer cell 
surface. For example, Borup-Christensen P et al. have shown 
that the COU-1, a fusion form of antibody recognizes modified 
forms of keratins with molecular masses of approximately 43 kDa 
although the native cytokeratin 8 and 18 have molecular masses 
of 60kDa and 67kDa respectively [21,22]. Further COU-1 antibody 
has also been used in demonstrating the differential staining of 
membrane-associated cytokeratins on viable carcinoma cells 
and resting cells [23]. Taken together collectively, these results 
suggest that Keratin 1 is one of the major SRL interacting proteins 
in HT29 cells. 
Glycan array analysis of SRL has revealed its specificity towards 
TF antigen and TF associated O-linked glycans [14], considering 
this we checked for the presence of O-GalNAc sites in SRL affinity 
purified proteins by using NetOGlyc version 4.0. This is online 
software which predicts and records O-GalNAc glycosylation 
sites in the protein sequence and gives the prediction confidence 
scores and forecasts sites as glycosylated whose prediction 
confidence scores are higher than 0.5 and marks them with 
"#POSITIVE" string [20]. It is interesting to note the data analysed 
by NetOGlyc version 4.0 software revealed that, out of 25 SRL 
binding proteins identified by MS, 21 proteins were found to 
contain potential O-GalNAc sites and only other four proteins, 
namely alpha enolase, ADP-ribosylation factor 1, protein S100-A6 
and tubulin alpha-1B chain were negative for O-glycosylation 
sites. Since affinity column was blocked with BSA to avoid 
nonspecific protein-protein interaction, these 4 nonglycosylated 
proteins captured by affinity column may be through indirect 
lectin binding (lectin-target glycoprotein-non-target proteins). 
SRL interacting keratins showed 27 to 50 O-GalNAc sites in their 
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sequences. Keratin 1 validated as one of the SRL binding protein 
contains 49 potential O-GalNAc sites. ATP synthase subunit alpha, 
mitochondrial, Retinal dehydrogenase 1, HSP-60, annexin-A2 
and pyruvate kinase M1/M2 contains 10, 6, 5, 4 and 3 O-GalNAc 
sites respectively. Other SRL interacting proteins, prohibitin, 
HSP-90, actin cytoplasmic-2 and peroxiredoxin-1 contain two 
O-GalNAc sites. ADP/ATP translocase-2, tubulin beta-4B chain 
and elongation factor 1-alpha-2 contain one O-GalNAc site. Taken 
together, the analysis suggests that almost all of the SRL-affinity 
pull down proteins contain potential O-GalNAc sites which further 
support affinity of SRL towards O-glycans [14].
Lectins due to their sugar recognition property have been 
valuable tools in identifying glycoconjugates, examples include 
ConA and WGA. N-glycoproteins from liver cells were identified 
by using ConA and WGA affinity columns [24] and interestingly 
few of these identified proteins overlapped with SRL binding 
proteins. Keratin 1, Keratin 10 and alpha enolase are the common 
glycoproteins identified by these lectins. Annexin-A2, pyruvate 
kinase and prohibitin were recognised by WGA and SRL. Keratin 
18 was recognised by ConA and SRL. SRL, ConA and WGA also 
recognised common family of proteins namely tubulins, heat shock 
proteins and elongation factors. ConA and WGA have specificity 
for N-glycoproteins and SRL recognizes mostly O-glycoproteins 
hence these common proteins recognised by these lectins may 
contain both N and O-glycans. Keratin 1 is identified as one of 
the SRL interacting protein in HT29 cells. Recognition of keratins 
by lectins has been reported earlier for example, galactose 
specific lectins such as recognising keratins, GCA, a galectin from 
the sponge Geodia cydonium, VVA-B4, tetrameric isolectin B4 
from Vicia villosa and SBA, lectin from Glycine max are known 
to recognize keratins, Keratin 8, Keratin 18, and Keratin 19 from 
MCF7 cells [25].
Keratins are part of the family of intermediate filament proteins 
participating in the cytoskeletal assembly of cells. However recent 
studies have shown that functions of keratins are not restricted 
as structural proteins but they are also involved in cell signalling, 
apico-basal polarization, motility, cell size, protein synthesis 
and membrane trafficking. Keratins are used as diagnostic and 
prognostic tumor markers and are also recognised as a new class 
of receptors, for example membrane expression of keratin 1 by 
HUVEC cells has been shown and it is identified as kininogen 
receptor [26-28]. These reports support role of keratins as 
membrane receptors.
Apart from keratins, SRL also recognises other HT29 proteins with 
O-GalNAc sites namely, prohibitin, annexin-A2, peroxiredoxin 1, 
pyruvate kinase, heat shock proteins as identified by MS that 
are linked to apoptosis, cancer cell proliferation and metastasis. 
Prohibitin (PHB) has been localized to mitochondria, plasma 
membrane and nucleus and has biological role in mitochondrial 
function, cell proliferation and development. Phosphorylation of 
PHB by Akt, TGF-b or Ras ⁄ Raf pathways favours cell proliferation 
hence inhibition of PHB phosphorylation is hypothesized to 
inhibit cell proliferation [29]. O-GlcNAc modification and tyrosine 
phosphorylation of PHB has shown to play a significant role in 
tyrosine kinase signalling pathways namely, insulin, growth 
factors and immune receptors signalling [30]. Over expression of 
PHB is reported in lung, prostate carcinoma and liver cancer cells 
and its expression levels is correlated with the proliferation and 
metastasis of liver cancer cells [31]. Hence integrated targeting of 
multiple functions of PHB may affect diverse signalling pathways 
and in turn inhibits cancer cell growth. SRL may be inducing its 
observed apoptotic effect in HT29 cells by binding to PHB and 
inhibiting its tumorigenic effect.
Annexin-A2 (Axn A2), another SRL binding protein is localized 
to the plasma membrane of endothelial cells, tumor cells and 
regulates diverse cellular functions, including angiogenesis, 
proliferation, apoptosis, cell migration, invasion and adhesion. 
Cell surface Anx A2 complexes with plasminogen and tissue 
plasminogen activator, activates plasmin and thereby is linked 
to cancer metastasis [32]. Over-expression of Axn A2 has been 
reported in breast, liver, prostate, gliomas and cancer of pancreas 
and its expression is correlated with cancer invasion and 
metastasis. Hence targeting Anx A2 is also considered as a novel 
therapeutic strategy to inhibit tumor growth [33].
Pyruvate kinase (PK) catalyzes a rate-limiting final reaction in 
glycolysis, generating pyruvate and ATP. An ample amount of 
energy is required for survival of cancer cells and uses glycolysis as 
primary source of energy production also called aerobic glycolysis 
or the Warburg effect [34] and is regulated by pyruvate kinase M2 
(PKM2). Studies have shown that PKM2 is overexpressed in many 
cancer cells including colon cancer and is correlated with colon 
cancer proliferation and metastasis. Overexpression of PKM2 also 
promotes CRC cell migration and cell adhesion by regulating STAT3-
associated signalling [35]. In contrast, inhibition/knockdown of 
PKM2 resulted in the suppression of xenograft tumor growth in 
vivo and thus PKM2 is considered as a potential therapeutic target 
for CRC [36]. Nonglycolytic role of PKM2 is reported in nucleus of 
cancer cells, where it activates transcription of many genes and 
favours cancer growth [37]. Interaction of SRL with PKM2 is likely 
to block its tumour promoting activity.
Peroxiredoxin-1 (Pxr-1) regulates hydrogen peroxide signalling, acts 
as a protein chaperone and immune modulator. Overexpression 
of Prx-1 is reported in many cancers and influences diverse cellular 
processes including cell survival, proliferation and apoptosis. Pxr-
1 overexpression is correlated with poor clinical outcomes and 
diminished overall patient survival [38,39]. Heat shock proteins 
(HSPs) are vital molecular players in the cellular stress response. 
HSPs prevent cell death, for instance by preventing caspase-
dependent (e.g., HSP27, HSP70, and HSP90) and/or independent 
(e.g., HSP70) pathways [40]. However, some HSPs induce cell death, 
for instance, HSP60/HSP10/pro-caspase complex triggers apoptosis 
in jurkat cells [41]. Conversely, HSP60 overexpression is reported in 
various tumors including cervical cancer and is correlated with tumor 
carcinogenesis [42]. HSP90 regulates and stabilizes deregulated 
proteins involved in apoptosis, signal-transduction pathways and 
cell-cycle regulation thereby stabilizes tumorogenic cells. Hence 
HSP90 is considered as a potential target for drug screening. HSP90 
inhibitors such as geldanamycin, 17AAG, 17DMAG, radicicol, oxime 
derivatives, purine-scaffold inhibitors and novobiocin are used to 
study their anticancer effect and some of these are in Phase I and 
Phase II clinical trials [43]. Hence interaction of SRL with HSP90 is 
likely to block its tumorigenic effect.
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Actin has manifold biological functions including cell contraction, 
motility, vesicle trafficking, intracellular organization, cytokinesis, 
endocytosis and apoptosis. Actin cytoskeleton is shown to act 
both as a sensor and mediator of apoptosis [44]. Disruption of 
actin filament integrity with cytochalasin D and jasplakinolide is 
shown to induce apoptosis in airway epithelial cells [45]. SRL may 
be binding to and altering the actin filament integrity in HT29 cells 
thereby inducing observed HT29 cellular apoptosis. The present 
study supports the activation of multiple signalling pathways by 
SRL [18] possibly by binding to more than one membrane proteins 
and inducing apoptosis in colon cancer HT29 cells.
Conclusion
In conclusion, SRL interacting membrane proteins containing 
O-GalNAc sites from human colon epithelial cancer HT29 cells 
have been purified, identified and characterized and interestingly 
all of them have their reported functions that is concerned with 
cell survival, angiogenesis or cellular apoptosis. Hence it is likely 
that SRL induces cellular apoptosis as reported earlier by binding 
to and inhibiting/altering the function of these identified proteins 
implicated in cancer cell progression and metastasis, however it 
needs further detailed investigation to identify which of these 
protein initiates cellular apoptosis following its interaction with 
the lectin. The present study provides insights in studying the 
mechanism of SRL induced apoptosis and to explore lectin for its 
clinical implications.
Supporting Information
Supporting information 1 presents prediction of O-GalNAc sites 
of Keratin-1 by NetOGlyc version 4.0.
Funding
This work has been supported by Agilent Technologies, Santa 
Clara, CA, United States of America under University Research 
(ACT UR), British council, UKIERI, UGC sponsored UPE and CPEPA 
and DBT-BIRAC. 
Competing Interests
The authors declare that they have no competing interest.
11
ARCHIVOS DE MEDICINA
ISSN 1698-9465
2015
Special Issue
Translational Biomedicine
ISSN 2172-0479
© Copyright iMedPub                                                                                                                                                                            Find this article in: www.transbiomedicine.com
References
1 VanDamme EJM, Lannoo N, Peumans WJ (2008) In plant lectins. Adv 
Botan Re 48: 107-209.
2 Stanley P, Sudo T (1981) Microheterogeneity among carbohydrate 
structures at the cell surface may be important in recognition 
phenomena. Cell 23: 763-9.
3 Zanetta JP, Kuchler S, Lehmann S, Badache A, Maschke S, et al. 
(1992) Glycoproteins and lectins in cell adhesion and cell recognition 
processes. Histochem J 24: 791-804.
4 Mody R, Joshi SH, Chaney W (1995) Use of lectins as diagnostic 
and therapeutic tools for cancer.  J Pharmacological Toxicological 
Methods 33: 1-10.
5 Konska G (2006) Lectins of Higher Fungi (Macromycetes) - their 
occurrence, physiological role, and biological activity. Int J Med 
Mushr 8: 19-30.
6 Liu B, Zhang B, Min MW, Bian HJ, Chen LF, et al. (2009) Induction 
of apoptosis by Polygonatum odoratum lectin and its molecular 
mechanisms in murine fibrosarcoma L929 cells. Biochim Biophys 
Acta 1790: 840-844.
7 Yu LG (2007) The oncofetal Thomsen-Friedenreich carbohydrate 
antigen in cancer progression. Glycoconj J 24: 411-20.
8 Singh R, Subramanian S, Rhodes JM, Campbell BJ (2006) Peanut 
lectin stimulates proliferation of colon cancer cells by interaction 
with glycosylated CD44v6 isoforms and consequential activation 
of c-Met and MAPK: functional implications for disease-associated 
glycosylation changes. Glycobiology 16: 594-601
9 Yu LG, Packman LC, Weldon M, Hamlett J,  Rhodes JM (2004) Protein 
phosphatase 2A, a negative regulator of the ERK signaling pathway, 
is activated by tyrosine phosphorylation of putative HLA class II-
associated protein I (PHAPI)/pp32 in response to the antiproliferative 
lectin, jacalin. J Biol Chem 279: 41377-83.
10 Alperin DM, Latter H, Lis H, Sharon N (1992) Isolation, by affinity 
chromatography and gel filtration in 8 M-urea, of an active subunit 
from the anti-(blood-group A+N)-specific lectin of Moluccella laevis. 
Biochem J 285 (Pt 1): 1-4.
11 Swamy BM, Hegde GV, Naik RS, Inamdar SR (2001) T-antigen binding 
lectin from the phytopathogenic fungus Sclerotium rolfsii. Lect Biol 
Biochem Clin Biochem 15: 45-55 (http://plab.ku.dk/tcbh/Lectins15/
Swamy/paper.htm).
12 Swamy BM, Bhat AG, Hegde GV, Naik RS, Kulkarni S,  et al. (2004) 
Immunolocalization and functional role of Sclerotium rolfsii lectin in 
development of fungus by interaction with its endogenous receptor. 
Glycobiology 14: 951-7.
13 Leonidas DD, Swamy BM, Hatzopoulos GN, Gonchigar SJ, Chachadi 
VB, et al. (2007) Structural basis for the carbohydrate recognition of 
the Sclerotium rolfsii lectin. J Mol Biol 368: 1145-61.
14 Chachadi  VB, Inamdar SR, Yu LG, Rhodes JM,  Swamy BM (2011) 
Exquisite binding specificity of Sclerotium rolfsii lectin toward TF-
related O-linked mucin-type glycans. Glycoconj J 28: 49-56.
15 Inamdar SR, Savanur MA, Eligar SM, Chachadi VB, Nagre NN, et al. 
(2012) The TF-antigen binding lectin from Sclerotium rolfsii inhibits 
growth of human colon cancer cells by inducing apoptosis in vitro 
and suppresses tumor growth in vivo. Glycobiology 22: 1227-35.
16 Eligar SM, Pujari R, Swamy BM, Shastry P, Inamdar SR (2012) 
Sclerotium rolfsii lectin inhibits proliferation and induces apoptosis 
in human ovarian cancer cell line PA-1. Cell Prolif 45: 397-403.
17 Savanur MA, Eligar SM, Pujari R, Chen C, Mahajan P, et al. (2014) 
Sclerotium rolfsii Lectin Induces Stronger Inhibition of Proliferation in 
Human Breast Cancer Cells than Normal Human Mammary Epithelial 
Cells by Induction of Cell Apoptosis. PLoS One 9:e110107.
18 Barkeer S, Guha N, Hothpet V, Deepak SA, Hegde P, et al. (2015) 
Molecular mechanism of anti-cancer effect of Sclerotium rolfsii lectin 
in HT29 cells involves differential expression of genes associated with 
multiple signalling pathways; A microarray analysis. Glycobiology In 
press.
19 March SC, Parikh I, Cuatrecasas P (1974) A simplified method for 
cyanogen bromide activation of agarose for affinity chromatography. 
Anal Biochem 60: 149-52.
20 Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen 
MB, et al. (2013) Precision mapping of the human O-GalNAc 
glycoproteome through SimpleCell technology. EMBO J 32: 1478-88.
21 Borup-Christensen P, Erb K, Jensenius JC, Nielsen B, Svehag SE (1986) 
Human-human hybridomas for the study of anti-tumor immune 
response in patients with colorectal cancer. Int J Cancer 37: 683-8.
22 Erb K, Borup-Christensen P, Ditzel H, Chemnitz J, Haas H, et al. (1992) 
Characterization of a human-human hybridoma antibody, C-OU1, 
directed against a colon tumor-associated antigen. Hybridoma 11: 
121-34.
23 Henrik JD, Ursula G, Claus  BD, Morten  KL, H JG, et al. (1995) Modified 
cytokeratins expressed on the surface of carcinoma cells undergo 
endocytosis upon binding of human monoclonal antibody and its 
recombinant Fab fragment. Proc Natl Acad  Sci USA 94: 8110-8115.
24 Xu Z, Zhou X, Lu H, Wu N, Zhao H, et al. (2007) Comparative 
glycoproteomics based on lectins affinity capture of N-linked 
glycoproteins from human Chang liver cells and MHCC97-H cells. 
Proteomics 7: 2358-70.
25 Goletz S, Hanisch FG, Karsten U (1997) Novel alphaGalNAc containing 
glycans on cytokeratins are recognized invitro by galectins with type 
II carbohydrate recognition domains. J Cell Sci 110 ( Pt 14): 1585-96.
26 Karantza V (2011) Keratins in health and cancer: more than mere 
epithelial cell markers. Oncogene 30: 127-38.
27 Ahmed AKH, Timothy Z, Alvin HS (1998) Identification of cytokeratin 
1 as a binding protein and presentation receptor for kininogens on 
endothelial cells. Proc  Natl Acad Sci USA 95: 3615-3620.
28 Astern JM, Pendergraft WF, Falk RJ, Jennette JC, Schmaier AH, et 
al. (2007) Myeloperoxidase interacts with endothelial cell-surface 
cytokeratin 1 and modulates bradykinin production by the plasma 
Kallikrein-Kinin system. Am J Pathol 171: 349-60.
29 Mishra S, Ande SR, Nyomba BL (2010) The role of prohibitin in cell 
signaling. FEBS J 277: 3937-46.
30 Ande SR, Moulik S, Mishra S (2009) Interaction between O-GlcNAc 
modification and tyrosine phosphorylation of prohibitin: implication 
for a novel binary switch. PLoS One 4: e4586.
31 Xu Z, Wu J,  Zha X (2011) Up-regulation of prohibitin 1 is involved in 
the proliferation and migration of liver cancer cells. Sci China Life Sci 
54: 121-7.
32 Lokman NA, Ween MP, Oehler MK, Ricciardelli C (2011) The role 
of annexin A2 in tumorigenesis and cancer progression. Cancer 
Microenviron 4: 199-208.
33 Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, et al. (2011) 
12
© Copyright iMedPub                                                                                                                                                                            Find this article in: www.transbiomedicine.com
ARCHIVOS DE MEDICINA
ISSN 1698-9465
2015
Special Issue
Translational Biomedicine
ISSN 2172-0479
Annexin A2 promotes glioma cell invasion and tumor progression. J 
Neurosci 31: 14346-60.
34 Warburg O, Wind F, Negelein E (1927) The Metabolism of Tumors in 
the Body. J Gen Physiol 8: 519-30.
35 Yang P, Li Z, Fu R, Wu H (2014) Pyruvate kinase M2 facilitates colon 
cancer cell migration via the modulation of STAT3 signalling. Cell 
Signal 26: 1853-62.
36 Zhou CF, Li XB, Sun H, Zhang B, Han YS, et al. (2012) Pyruvate 
kinase type M2 is upregulated in colorectal cancer and promotes 
proliferation and migration of colon cancer cells. IUBMB Life 64: 775-
82.
37 Tamada M, Suematsu M, Saya H (2012) Pyruvate kinase M2: multiple 
faces for conferring benefits on cancer cells. Clin Cancer Res 18: 
5554-61.
38 Kim JH, Bogner PN, Baek SH, Ramnath N, Liang P, et al. (2008) Up-
regulation of peroxiredoxin 1 in lung cancer and its implication as a 
prognostic and therapeutic target. Clin Cancer Res 14: 2326-33.
39 Riddell JR, Wang XY, Minderman H, Gollnick SO (2010) Peroxiredoxin 
1 stimulates secretion of proinflammatory cytokines by binding to 
TLR4. J Immunol 184: 1022-30.
40 Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune 
system. Curr Opin Immunol 13: 114-9.
41 Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S (1999) Presence 
of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in 
the mitochondrial fraction of jurkat cells. EMBO J 18: 2040-8.
42 Hwang YJ, Lee SP, Kim SY, Choi YH, Kim MJ, et al. (2009) Expression 
of heat shock protein 60 kDa is upregulated in cervical cancer. Yonsei 
Med J 50: 399-406.
43 Gava LM, Ramos CHI (2009) Human 90 kDa Heat Shock Protein 
Hsp90 as a Target for Cancer Therapeutics. Current Chemical Biolog 
3: 10-21.
44 Desouza M, Gunning PW, Stehn JR (2012) The actin cytoskeleton as a 
sensor and mediator of apoptosis. Bioarchitecture 2: 75-87.
45 White SR, Williams P, Wojcik KR, Sun S, Hiemstra PS, et al. (2001) 
Initiation of apoptosis by actin cytoskeletal derangement in human 
airway epithelial cells. Am J Respir Cell Mol Biol 24: 282-94.
An Original publication of ImedPub in a Special Issue-Recent 
Advancements in Molecular and Translational Biomedicine, 
Edited by Dr. Ashish R Patil, University of Pittsburgh, USA.
